Clinical Trial Update: Prostate Boost Irradiation With Stereotactic Body RT (SBRT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating prostate boost irradiation using stereotactic body radiotherapy (SBRT) for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Juravinski Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN